Yayın:
Crizotinib efficacy in alk-positive advanced stage non-small cell lung cancer patients: A real-world experience from Turkey

dc.contributor.authorKılıçkap, S.
dc.contributor.authorÖztürk, A.
dc.contributor.authorKaradurmuş, N.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorYumuk, P.
dc.contributor.authorCicin, I.
dc.contributor.authorPaydaş, S.
dc.contributor.authorCilbir, E.
dc.contributor.authorSakalar, T.
dc.contributor.authorUysal, M.
dc.contributor.authorUskent, N.
dc.contributor.authorDemir, N.
dc.contributor.authorSakin, A.
dc.contributor.authorTurhal, N.
dc.contributor.authorKeskin, S.
dc.contributor.authorTural, D.
dc.contributor.authorEralp, Y.
dc.contributor.authorBasal, F.
dc.contributor.authorYaşar, H.
dc.contributor.authorSendur, M. A.
dc.contributor.authorDemirci, U.
dc.contributor.authorÇubukcu, Erdem
dc.contributor.authorKaraağaç, M.
dc.contributor.authorKaraca, S.
dc.contributor.authorTatlı, A.
dc.contributor.authorYetişyiğit, T.
dc.contributor.authorUrvay, S.
dc.contributor.authorGürsoy, P.
dc.contributor.authorUluc, B. Oyan
dc.contributor.authorTurna, Z.
dc.contributor.authorKüçükoner, M.
dc.contributor.authorÇlmez, O.
dc.contributor.authorÇabuk, D.
dc.contributor.authorŞeker, M.
dc.contributor.authorÜnal, O.
dc.contributor.authorMeydan, N.
dc.contributor.authorOkutur, S.
dc.contributor.authorTunalı, D.
dc.contributor.buuauthorÇUBUKÇU, ERDEM
dc.contributor.departmentTıp Fakültesi
dc.contributor.researcheridJGT-4101-2023
dc.date.accessioned2024-07-25T11:26:14Z
dc.date.available2024-07-25T11:26:14Z
dc.date.issued2018-10-01
dc.identifier.eissn1556-1380
dc.identifier.endpageS478
dc.identifier.issn1556-0864
dc.identifier.issue10
dc.identifier.startpageS477
dc.identifier.urihttps://hdl.handle.net/11452/43443
dc.identifier.volume13
dc.identifier.wos000454014501235
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherElsevier
dc.relation.journalJournal of Thoracic Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNsclc
dc.subjectAlk inhibitor
dc.subjectCrizotinib
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectRespiratory system
dc.subjectOncology
dc.titleCrizotinib efficacy in alk-positive advanced stage non-small cell lung cancer patients: A real-world experience from Turkey
dc.typeOther
dc.type.subtypeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi
local.indexed.atWOS
relation.isAuthorOfPublicationf971677f-09c5-4463-bf01-3c6341fbe5f7
relation.isAuthorOfPublication.latestForDiscoveryf971677f-09c5-4463-bf01-3c6341fbe5f7

Dosyalar